STORTI, Paola
STORTI, Paola
Dipartimento di Medicina e Chirurgia
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome
2014-01-01 Colla, Simona; Ong, Derrick; Ogoti, Yamini; Marchesini, Matteo; Mistry, Nipun; Clise Dwyer, Karen; Storti, Paola; Viale, Andrea; Wei, Yue; Giuliani, Nicola; Yang, Hui; D'Anca, Marianna; Estecio, Marcos R.; Liang, Han; Kantarjian, Hagop M.; Wang, Alan Y.; Chin, Lynda; Bueso Ramos, Carlos E.; Garcia Manero, Guillermo; Depinho, Ronald
A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors
2022-01-01 Raimondi, Vincenzo; Iannozzi, Nicolas Thomas; Burroughs-Garcìa, Jessica; Toscani, Denise; Storti, Paola; Giuliani, Nicola
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment
2008-01-01 Giuliani, Nicola; Colla, S; Storti, Paola; Donofrio, Gaetano; Bolzoni, Marina; Bonomini, S; Galla, L; Sammarelli, Gabriella; Mangoni, M; Rizzoli, Vittorio
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma
2014-01-01 Accardi, Fabrizio; Chiu, Martina; Bolzoni, Marina; Storti, Paola; Todoerti, Katia; Agnelli, Luca; Ferrari, Massimiliano; Missale, Gabriele; Aversa, Franco; Bussolati, Ovidio; Giuliani, Nicola
Angiogenesis and multiple myeloma
2011-01-01 Giuliani, Nicola; Storti, Paola; Bolzoni, Marina; Palma, Bd; Bonomini, S.
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma
2020-01-01 Manzoni, M.; Marchica, V.; Storti, P.; Ziccheddu, B.; Sammarelli, G.; Todaro, G.; Pelizzoni, F.; Salerio, S.; Notarfranchi, L.; Pompa, A.; Baldini, L.; Bolli, N.; Neri, A.; Giuliani, N.; Lionetti, M.
Are the Myeloma bone microevironment cells tumoral or not?
2009-01-01 Giuliani, Nicola; Novara, F; Todoerti, K; Zaffaroni, N; Villa, R; Storti, Paola; Bernardo, Me; Manferdini, C; Gabusi, E; Abeltino, Manuela; Bolzoni, Marina; Agnelli, L; Rocci, A; Colla, S; Sammarelli, Gabriella; Rizzoli, Vittorio; Zuffardi, O; Neri, A; Lisignoli, G.
ASSESSMENT OF THE INTERLABORATORY VARIABILITY AND ROBUSTNESS OF JAK2V617F MUTATION ASSAYS: A STANDARDIZATION STUDY INVOLVING A CONSORTIUM OF 19 ITALIAN LABORATORIES
2016-01-01 Perricone, M; Palandri, F; Angelini, M; Bagli, L; Bellesia, E; Donati, M; Gemmati, D; Giannini, B; Zucchini, P; Mancini, S; Storti, Paola; Trubini, S; De Matteis, G; Di Zacomo, S; Favarato, M; Fioroni, Ma; Gusella, M; Maccari, G; Navaglia, F; Svaldi, M; Toffolatti, L; Orlandi, L; Laloux, V; Manfrini, M; Cuneo, A; Galieni, P; Marasca, R; Pazzaglia, ; Sensi, A; Tieghi, A; Giuliani, Nicola; Leoni, P; Vallisa, D; Bonifacio, M; Di Bartolomeo, P; Fazio, V; Gatti, D; Gherlinzoni, F; Paolini, R; Plebani, M; Tiribelli, M; Cassavia, F; Orsini, F; Cavo, M; Ottaviani, E; Martinelli, G.
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis
2014-01-01 Bolzoni, Marina; Storti, Paola; Guasco, D; Ronchetti, D; Agnelli, L; Costa, Federica; Bonomini, S; Dalla Palma, B; Craviotto, Luisa; Neri, A; Aversa, Franco; Giuliani, Nicola
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients
2019-01-01 Marchica, Valentina; Toscani, Denise; Corcione, Anna; Bolzoni, Marina; Storti, Paola; Vescovini, Rosanna; Ferretti, Elisa; Palma, Benedetta Dalla; Vicario, Emanuela; Accardi, Fabrizio; Mancini, Cristina; Martella, Eugenia; Ribatti, Domenico; Vacca, Angelo; Pistoia, Vito; Giuliani, Nicola
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma
2018-01-01 Dalla Palma, Benedetta; Marchica, Valentina; Pedrazzoni, Mario; Accardi, Fabrizio; Notarfranchi, Laura; Goldoni, Matteo; De Luca, Federica; Costa, Federica; Storti, Paola; Toscani, Denise; Sammarelli, Gabriella; Bonomini, Sabrina; Aversa, Franco; Giuliani, Nicola
Bone marrow monocyte / macrophage derived activin a mediates the osteoclastogenic effects of IL-3 in myeloma
2011-01-01 Silbermann, R; Bolzoni, Marina; Storti, Paola; Dalla Palma, B; Bonomini, S; Anderson, J; Roodman D, G; Giuliani, Nicola
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma
2014-01-01 Silbermann, R; Bolzoni, Marina; Storti, Paola; Guasco, D; Bonomini, S; Zhou, D; Wu, J; Anderson, Jl; Windle, Jj; Aversa, Franco; David Roodman, G; Giuliani, Nicola
Bone microenvironment cells show a different pattern of gene expression profiling in relationship with the presence of osteolytic bone lesions in Multiple Myeloma patients
2008-01-01 Todoerti, K; Lisignoli, G; Colla, S; Storti, Paola; Agnelli, L; Manferdini, C; Verdelli, D; Crugnola, M; Codeluppi, K; Lambertenghi Deliliers, G; Rizzoli, V; Neri, A; Giuliani, Nicola
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients
2010-01-01 Giuliani, Nicola; Lisignoli, G; Novara, F; Storti, Paola; Zaffaroni, N; Villa, R; Sammarelli, G; Agnelli, L; Todoerti, K; Bernardo, Me; Manferdini, C; Colla, S; Abeltino, M; Bolzoni, Marina; Rocci, A; Gabusi, E; Palumbo, A; Zuffardi, O; Neri, A; Rizzoli, Vittorio
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
2020-01-01 Marchica, Valentina; Franceschi, Valentina; Vescovini, Rosanna; Storti, Paola; Vicario, Emanuela; Toscani, Denise; Zorzoli, Alessia; Airoldi, Irma; Dalla Palma, Benedetta; Campanini, Nicoletta; Martella, Eugenia; Mancini, Cristina; Costa, Federica; Donofrio, Gaetano; Giuliani, Nicola
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment
2010-01-01 Giuliani, Nicola; Bolzoni, Marina; Abeltino, Manuela; Storti, Paola; Sgobba, V; Bonomini, S; Pariyyarath, R; Rizzoli, Vittorio
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions
2008-01-01 Giuliani, Nicola; Lisignoli, G; Colla, S; Lazzaretti, Mirca; Storti, Paola; Mancini, C; Bonomini, S; Manfredini, C; Codeluppi, K; Rizzoli, Vittorio
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy
2020-01-01 Storti, P.; Vescovini, R.; Costa, F.; Marchica, V.; Toscani, D.; Dalla Palma, B.; Craviotto, L.; Malavasi, F.; Giuliani, N.
Comet assay and prediction of clinical outcome after DNA-damaging drugs treatment
2009-01-01 Galati, S; Buschini, Annamaria; Lazzaretti, M; Poli, Paola; Ferraro, F; Bonomini, S; Frati, Caterina; Storti, Paola; Rizzoli, V; Rossi, C; Quaini, Federico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome | 1-gen-2014 | Colla, Simona; Ong, Derrick; Ogoti, Yamini; Marchesini, Matteo; Mistry, Nipun; Clise Dwyer, Karen; Storti, Paola; Viale, Andrea; Wei, Yue; Giuliani, Nicola; Yang, Hui; D'Anca, Marianna; Estecio, Marcos R.; Liang, Han; Kantarjian, Hagop M.; Wang, Alan Y.; Chin, Lynda; Bueso Ramos, Carlos E.; Garcia Manero, Guillermo; Depinho, Ronald | |
| A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors | 1-gen-2022 | Raimondi, Vincenzo; Iannozzi, Nicolas Thomas; Burroughs-Garcìa, Jessica; Toscani, Denise; Storti, Paola; Giuliani, Nicola | |
| Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment | 1-gen-2008 | Giuliani, Nicola; Colla, S; Storti, Paola; Donofrio, Gaetano; Bolzoni, Marina; Bonomini, S; Galla, L; Sammarelli, Gabriella; Mangoni, M; Rizzoli, Vittorio | |
| Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma | 1-gen-2014 | Accardi, Fabrizio; Chiu, Martina; Bolzoni, Marina; Storti, Paola; Todoerti, Katia; Agnelli, Luca; Ferrari, Massimiliano; Missale, Gabriele; Aversa, Franco; Bussolati, Ovidio; Giuliani, Nicola | |
| Angiogenesis and multiple myeloma | 1-gen-2011 | Giuliani, Nicola; Storti, Paola; Bolzoni, Marina; Palma, Bd; Bonomini, S. | |
| Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma | 1-gen-2020 | Manzoni, M.; Marchica, V.; Storti, P.; Ziccheddu, B.; Sammarelli, G.; Todaro, G.; Pelizzoni, F.; Salerio, S.; Notarfranchi, L.; Pompa, A.; Baldini, L.; Bolli, N.; Neri, A.; Giuliani, N.; Lionetti, M. | |
| Are the Myeloma bone microevironment cells tumoral or not? | 1-gen-2009 | Giuliani, Nicola; Novara, F; Todoerti, K; Zaffaroni, N; Villa, R; Storti, Paola; Bernardo, Me; Manferdini, C; Gabusi, E; Abeltino, Manuela; Bolzoni, Marina; Agnelli, L; Rocci, A; Colla, S; Sammarelli, Gabriella; Rizzoli, Vittorio; Zuffardi, O; Neri, A; Lisignoli, G. | |
| ASSESSMENT OF THE INTERLABORATORY VARIABILITY AND ROBUSTNESS OF JAK2V617F MUTATION ASSAYS: A STANDARDIZATION STUDY INVOLVING A CONSORTIUM OF 19 ITALIAN LABORATORIES | 1-gen-2016 | Perricone, M; Palandri, F; Angelini, M; Bagli, L; Bellesia, E; Donati, M; Gemmati, D; Giannini, B; Zucchini, P; Mancini, S; Storti, Paola; Trubini, S; De Matteis, G; Di Zacomo, S; Favarato, M; Fioroni, Ma; Gusella, M; Maccari, G; Navaglia, F; Svaldi, M; Toffolatti, L; Orlandi, L; Laloux, V; Manfrini, M; Cuneo, A; Galieni, P; Marasca, R; Pazzaglia, ; Sensi, A; Tieghi, A; Giuliani, Nicola; Leoni, P; Vallisa, D; Bonifacio, M; Di Bartolomeo, P; Fazio, V; Gatti, D; Gherlinzoni, F; Paolini, R; Plebani, M; Tiribelli, M; Cassavia, F; Orsini, F; Cavo, M; Ottaviani, E; Martinelli, G. | |
| Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis | 1-gen-2014 | Bolzoni, Marina; Storti, Paola; Guasco, D; Ronchetti, D; Agnelli, L; Costa, Federica; Bonomini, S; Dalla Palma, B; Craviotto, Luisa; Neri, A; Aversa, Franco; Giuliani, Nicola | |
| Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients | 1-gen-2019 | Marchica, Valentina; Toscani, Denise; Corcione, Anna; Bolzoni, Marina; Storti, Paola; Vescovini, Rosanna; Ferretti, Elisa; Palma, Benedetta Dalla; Vicario, Emanuela; Accardi, Fabrizio; Mancini, Cristina; Martella, Eugenia; Ribatti, Domenico; Vacca, Angelo; Pistoia, Vito; Giuliani, Nicola | |
| Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma | 1-gen-2018 | Dalla Palma, Benedetta; Marchica, Valentina; Pedrazzoni, Mario; Accardi, Fabrizio; Notarfranchi, Laura; Goldoni, Matteo; De Luca, Federica; Costa, Federica; Storti, Paola; Toscani, Denise; Sammarelli, Gabriella; Bonomini, Sabrina; Aversa, Franco; Giuliani, Nicola | |
| Bone marrow monocyte / macrophage derived activin a mediates the osteoclastogenic effects of IL-3 in myeloma | 1-gen-2011 | Silbermann, R; Bolzoni, Marina; Storti, Paola; Dalla Palma, B; Bonomini, S; Anderson, J; Roodman D, G; Giuliani, Nicola | |
| Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma | 1-gen-2014 | Silbermann, R; Bolzoni, Marina; Storti, Paola; Guasco, D; Bonomini, S; Zhou, D; Wu, J; Anderson, Jl; Windle, Jj; Aversa, Franco; David Roodman, G; Giuliani, Nicola | |
| Bone microenvironment cells show a different pattern of gene expression profiling in relationship with the presence of osteolytic bone lesions in Multiple Myeloma patients | 1-gen-2008 | Todoerti, K; Lisignoli, G; Colla, S; Storti, Paola; Agnelli, L; Manferdini, C; Verdelli, D; Crugnola, M; Codeluppi, K; Lambertenghi Deliliers, G; Rizzoli, V; Neri, A; Giuliani, Nicola | |
| Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients | 1-gen-2010 | Giuliani, Nicola; Lisignoli, G; Novara, F; Storti, Paola; Zaffaroni, N; Villa, R; Sammarelli, G; Agnelli, L; Todoerti, K; Bernardo, Me; Manferdini, C; Colla, S; Abeltino, M; Bolzoni, Marina; Rocci, A; Gabusi, E; Palumbo, A; Zuffardi, O; Neri, A; Rizzoli, Vittorio | |
| Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy | 1-gen-2020 | Marchica, Valentina; Franceschi, Valentina; Vescovini, Rosanna; Storti, Paola; Vicario, Emanuela; Toscani, Denise; Zorzoli, Alessia; Airoldi, Irma; Dalla Palma, Benedetta; Campanini, Nicoletta; Martella, Eugenia; Mancini, Cristina; Costa, Federica; Donofrio, Gaetano; Giuliani, Nicola | |
| CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment | 1-gen-2010 | Giuliani, Nicola; Bolzoni, Marina; Abeltino, Manuela; Storti, Paola; Sgobba, V; Bonomini, S; Pariyyarath, R; Rizzoli, Vittorio | |
| CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions | 1-gen-2008 | Giuliani, Nicola; Lisignoli, G; Colla, S; Lazzaretti, Mirca; Storti, Paola; Mancini, C; Bonomini, S; Manfredini, C; Codeluppi, K; Rizzoli, Vittorio | |
| CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy | 1-gen-2020 | Storti, P.; Vescovini, R.; Costa, F.; Marchica, V.; Toscani, D.; Dalla Palma, B.; Craviotto, L.; Malavasi, F.; Giuliani, N. | |
| Comet assay and prediction of clinical outcome after DNA-damaging drugs treatment | 1-gen-2009 | Galati, S; Buschini, Annamaria; Lazzaretti, M; Poli, Paola; Ferraro, F; Bonomini, S; Frati, Caterina; Storti, Paola; Rizzoli, V; Rossi, C; Quaini, Federico |